N-acetyl-seryl-aspartyl-lysyl-proline is a valuable endogenous antifibrotic peptide for kidney fibrosis in diabetes: An update and translational aspects
| Image |  |
|---|---|
| Description | scientific article published on 29 January 2020 |
| Author/s |
author: Keizo Kanasaki |
| Publication date | January 29, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |